3:59 PM
Dec 11, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Breast cancer

Mouse studies suggest combinations of bispecific small molecules targeting fluorescein and CAIX, PSMA or FOLR1 plus anti-fluorescein CAR T cells could help treat triple-negative breast cancer (TNBC). The bispecific adapter molecules consist of low molecular weight, small molecule ligands of CAIX, PSMA or FOLR1 linked to fluorescein. In mouse models of TNBC expressing CAIX,...

Read the full 258 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >